251 related articles for article (PubMed ID: 30623283)
1. Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.
Zhang Y; Wang M; Liu W; Peng X
Mol Imaging Biol; 2019 Oct; 21(5):835-841. PubMed ID: 30623283
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
[TBL] [Abstract][Full Text] [Related]
3. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
[TBL] [Abstract][Full Text] [Related]
4. MicroSPECT imaging of triple negative breast cancer cell tumor xenografted in athymic mice with radioiodinated anti-ICAM-1 monoclonal antibody.
You L; Wang X; Guo Z; Zhang D; Zhang P; Li J; Su X; Pan W; Zhang X
Appl Radiat Isot; 2018 Sep; 139():20-25. PubMed ID: 29684714
[TBL] [Abstract][Full Text] [Related]
5. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 as a molecular target for triple negative breast cancer.
Guo P; Huang J; Wang L; Jia D; Yang J; Dillon DA; Zurakowski D; Mao H; Moses MA; Auguste DT
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14710-5. PubMed ID: 25267626
[TBL] [Abstract][Full Text] [Related]
7. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
[TBL] [Abstract][Full Text] [Related]
8. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
[TBL] [Abstract][Full Text] [Related]
10. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
14. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC).
Zhang K; Liu Z; Yao Y; Qiu Y; Li F; Chen D; Hamilton DJ; Li Z; Jiang S
J Med Chem; 2021 Apr; 64(7):4020-4033. PubMed ID: 33745280
[TBL] [Abstract][Full Text] [Related]
16. An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.
Meng Q; Liu Z; Li F; Ma J; Wang H; Huan Y; Li Z
Mol Pharm; 2015 Jul; 12(7):2469-76. PubMed ID: 26030093
[TBL] [Abstract][Full Text] [Related]
17. Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
Xiao G; Annor GK; Fung K; Keinänen O; Zeglis BM; Bargonetti J
Mol Pharm; 2021 Jan; 18(1):338-346. PubMed ID: 33289569
[TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
Fukushima H; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Kondo E; Choyke PL; Kobayashi H
Cancer Sci; 2022 Sep; 113(9):3180-3192. PubMed ID: 35723065
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of magnetic near infrared fluorescent probe and targeted multimodal imaging of human mesenchymal stem cells in vitro].
Yan R; Qin J; Wang J; Liu J; Wu C; Ren L; Shan H
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):56-60. PubMed ID: 25876812
[TBL] [Abstract][Full Text] [Related]
20. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer.
Guo P; Yang J; Jia D; Moses MA; Auguste DT
Theranostics; 2016; 6(1):1-13. PubMed ID: 26722369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]